Researchers Found The Effect Of Fatty Acids

Researchers Found The Effect Of Fatty Acids.
Omega-3 fatty acids - nutrients large anticipation to be helpful for neurological health - can furious the usually impenetrable blood-brain barrier and make their way into the brain, a new study suggests Dec 2013. The conclusion could have implications for the use of omega-3s as a treatment for diseases such as Alzheimer's, the Swedish researchers said. As published in the Journal of Internal Medicine, scientists at the Karolinska Institute in Stockholm wanted to be taught how far in the in a tizzy system omega-3 fatty acids might travel.

And "Earlier citizens studies indicated that omega-3s can protect against Alzheimer's disease, which makes it interesting to investigate the effects of dietary supplements containing this group of fatty acids in patients who have already developed the disease," read lead author Dr Yvonne Freund-Levi said in an institute news release. The researchers said fatty acids store naturally in the central nervous practice of the fetus during gestation, and "it has been assumed that these acids are continually replaced throughout life". But whether this happens - and whether a person's sustenance makes a difference - has been unknown.

One key question: Do dietary fatty acids have the faculty to cross the brain's protective blood-brain barrier? This organically grown barrier shields the brain from harmful chemicals found elsewhere in the body, the researchers said. The delivery is particularly important for Alzheimer's disease research, because prior studies have shown that Alzheimer's patients have mark down levels of a key omega-3 fatty acid in the cerebrospinal fluid (the running that surrounds the central nervous system). In the six-month study, 18 patients with forgiving Alzheimer's disease got a daily omega-3 supplement while 15 patients received a placebo, or figure pill.

According to Freund-Levi's group, patients who got the supplement showed higher levels of two principal forms of omega-3 fatty acids in their cerebrospinal fluid - docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). The placebo set displayed no such change. Concentrations of DHA in cerebrospinal changeable were directly linked to the degree of change in Alzheimer's disease symptoms and in markers of redness in the fluid.

That's important, the researchers said, because reducing inflammation has been a proposed means of treating Alzheimer's disease. "The decision suggests that omega-3 fatty acids in dietary supplements crotchety the blood-brain barrier," co-author Jan Palmblad said in the news release.

So "However, much mix remains to be done before we know how these fatty acids can be used in the treatment of Alzheimer's disease to halt celebration loss". The study was funded with grants from the Capio Research Foundation, the Dementia Association, the Swedish Alzheimer's Association and Norwegian omega-3 processor Pronova Biocare A/S, all others vigrxbox.com. More information Find out more about omega-3 fatty acids and Alzheimer's disease at the Alzheimer's Association.